A Phase 1/2a, Open-label, Dose-escalation, Dose-expansion, Parallel Assignment Study to Evaluate the Safety and Clinical Activity of PBCAR0191 in Subjects with Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
NOT ENROLLING
Trial ID:
NCT03666000 Protocol # :
18-608
Phase
I/II
Disease Sites
Non-Hodgkin's Lymphoma
Lymphoid Leukemia
Principal Investigator
Jacobson, Caron, A
Site Research Nurses
Cummings, Kristen
O'Brien, Alexandra
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #18-608
18-608